claim: cepi establishes global network of laboratories to centralise assessment of covid-19 vaccine candidates
evidence_1: additionally, cepi is developing a worldwide network of drug product manufacturers that may be available for covax supported covid-19 vaccine manufacture.", "the network will use the same testing reagentsoriginating in the labs of nexelis and pheand follow common protocols to measure the immunogenicity of multiple covid-19 vaccine candidates (both cepi-funded and non-cepi funded developers).", "data obtained on the immunogenicity of cepi-funded vaccine candidates will be used to inform and advance cepis covid-19 vaccine portfolio by providing quick and accurate evaluation of its candidate vaccines."
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  )